FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets, Realm US

14,182 resources

Source: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 12,201

 

Start Prev Rows 1400 - 1600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1096.89.jsonInterventions Related to Care Coordination, Referrals for Specific Servicesactive2023-12hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1096.9.jsonReasons for Interventions Related to Medication Management, Dose Too Highactive2019-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1096.90.jsonRecommendations Related to Medication Regimen, Continue Medicationactive2017-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1096.91.jsonRecommendations Related to Medication Regimen, Initiate Medicationactive2017-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1096.92.jsonRecommendations Related to Medication Regimen, Change Medicationactive2021-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1096.93.jsonRecommendations Related to Medication Regimen, Change Medication Doseactive2017-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1096.94.jsonRecommendations Related to Medication Regimen, Change Medication Dosage Formactive2017-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1096.95.jsonRecommendations Related to Medication Regimen, Change Medication Courseactive2017-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1096.97.jsonRecommendations Related to Medication Regimen, Change Medication Dosing Intervalactive2017-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1096.98.jsonRecommendations Related to Medication Regimen, Discontinue Medicationactive2017-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1096.99.jsonRecommendations Related to Medication Regimen, Monitoringactive2021-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1099.12.jsonMedication Routeactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1099.24.jsonExtended Pregnancy Statusactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1099.33.jsonExternal Cause of Injury/Morbidityactive2025-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1099.35.jsonArthritis Feedback Types (SNOMED)active2019-12hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1099.36.jsonArthritis Feedback Types (LOINC)active2025-05hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1099.45.jsonBidirectional Services eReferral Typeactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1099.46.jsonBidirectional Services eReferral Reasonactive2025-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1099.50.jsonTransport vehicle typeactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1099.54.jsonSpecimen typeactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1099.55.jsonAt Home In Vitro Patient Questionsactive2024-08hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1099.58.jsonAcute COVID 19 Diagnosisactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1102.1.jsonCase Management for Behavioral Healthactive2021-12hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1102.63.jsonCase Management for Behavioral Healthactive2021-12hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1102.64.jsonCase Management for Behavioral Healthactive2021-12hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.124.jsonFollow Up Within 6 Monthsactive2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.125.jsonFollow Up Within 6 Monthsactive2024-01hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.126.jsonBone Scanactive2024-01hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.127.jsonBone Scanactive2024-01hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.15.jsonHospice Care Ambulatoryactive2024-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.175.jsonOffice and Wellness Visits for General Screeningactive2024-08hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.176.jsonOffice and Wellness Visits for General Screeningactive2024-08hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.177.jsonOffice and Wellness Visits for General Screeningactive2024-08hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.178.jsonOffice and Wellness Visits for General Screeningactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.28.jsonNon Acute Encounter Codes CPTactive2024-06hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.29.jsonNon Acute Encounter Codes HCPCSactive2024-06hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.31.jsonBleeding Event Diagnosis Codes ICD9active2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.78.jsonStatin Associated Muscle Symptomsactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.84.jsonStatin Associated Muscle Symptomsactive2024-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.85.jsonStatin Associated Muscle Symptomsactive2024-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1108.99.jsonUnderweightactive2022-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.11.jsonCornual Ectopic Pregnancyactive2021-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.12.jsonCornual Ectopic Pregnancyactive2021-06hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.13.jsonPerforation of Uterusactive2021-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.14.jsonPerforation of Uterusactive2021-06hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.15.jsonUterine Ruptureactive2021-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.16.jsonUterine Ruptureactive2021-06hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.17.jsonTransabdominal Cerclageactive2021-06hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.18.jsonTransabdominal Cerclageactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.2.jsonTransabdominal Cerclageactive2021-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.21.jsonIntravenous or Intraarterial Thrombolytic tPA Therapy Prior to Arrivalactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.23.jsonIntensive Care Unitactive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.24.jsonUterine Hornactive2021-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.25.jsonMetroplastyactive2021-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.3.jsonMedical Induction of Laboractive2021-06hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.35.jsonPlacenta Previaactive2021-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.36.jsonPlacenta Accreta Spectrum Previa or Vasa Previaactive2024-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.37.jsonPlacenta Accreta Spectrum Previa or Vasa Previaactive2023-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.38.jsonOutpatient Surgery Serviceactive2019-04hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.41.jsonStatin Allergenactive2022-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.42.jsonStatin Allergenactive2021-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.50.jsonRivaroxaban for VTE Prophylaxisactive2022-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.51.jsonPrasugrelactive2021-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.52.jsonPharmacological Contraindications For Antithrombotic Therapyactive2022-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.53.jsonAcute Renal Failureactive2024-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.54.jsonTotal Parenteral Nutritionactive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.55.jsonIntravenous Thrombolytic tPA Therapyactive2021-02hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.56.jsonIntraarterial Thrombolytic tPA Therapyactive2021-02hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.57.jsonIschemic Stroke Thrombosisactive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.58.jsonIschemic Stroke Thrombosisactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.59.jsonIschemic Stroke Otheractive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.60.jsonIschemic Stroke Otheractive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.61.jsonAntithrombotic Therapy Antiplateletactive2025-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.62.jsonAntithrombotic Therapy for Ischemic Strokeactive2021-04hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.63.jsonPresent On Admission is Yes or Exemptactive2022-01hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.64.jsonApplication of Venous Foot Pumpsactive2022-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.65.jsonApplication of Intermittent Pneumatic Compression Devicesactive2022-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.66.jsonApplication of Graduated Compression Stockingsactive2022-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.67.json20 to 42 Plus Weeks Gestationactive2023-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.68.json37 to 42 Plus Weeks Gestationactive2023-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.69.json37 to 38 Weeks Gestationactive2023-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.70.json20 to 42 Plus Weeks Gestationactive2023-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.71.json20 to 42 Plus Weeks Gestationactive2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.72.json37 to 42 Plus Weeks Gestationactive2023-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.73.json37 to 42 Plus Weeks Gestationactive2023-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.74.json37 to 38 Weeks Gestationactive2023-03hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.75.json37 to 38 Weeks Gestationactive2023-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.76.jsonHistory of Atrial Ablationactive2022-11hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.77.jsonPlacenta Accreta Spectrum Previa or Vasa Previaactive2024-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1110.78.jsonPlacenta Previaactive2023-11hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1111.143.jsonObservation Servicesactive2021-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1111.159.jsonAll Primary and Secondary Canceractive2023-03hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1111.161.jsonAll Primary and Secondary Canceractive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1111.163.jsonEmergency Department Evaluationactive2020-03hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1111.164.jsonAdmit Inpatientactive2021-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1111.171.jsonOpioid Use Disorderactive2024-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1111.173.jsonSickle Cell Disease with and without Crisis SNOMEDactive2024-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1111.174.jsonSickle Cell Disease with and without Crisis ICDactive2024-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1111.175.jsonSickle Cell Disease with and without Crisisactive2024-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1111.176.jsonOpioid Medication Assisted Treatment (MAT) HCPCSactive2024-02hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1111.177.jsonOpioid Medication Assisted Treatment (MAT)active2025-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1111.178.jsonCancer Related Pain ICD 10active2024-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1111.179.jsonCancer Related Pain SNOMEDactive2024-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1111.180.jsonCancer Related Painactive2024-02hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.10.jsonCare Experience Preferences at End of Life LOINCactive2024-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.12.jsonHealthcare Agent Ordinalityactive2020-12hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.14.jsonADIClauseTypeVSactive2022-08hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.17.jsonPreconditions for Treatment Preferencesactive2024-03hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.22.jsonAdvance Directive Document Typesactive2024-07hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.23.jsonAD Conditions and Prognosis Scenariosactive2023-08hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.26.jsonHealthcare Agent or Advisor Indicatoractive2024-03hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.27.jsonInitial Treatment portable medical order optionsactive2024-08hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.28.jsonCardiopulmonary Resuscitation Order Optionsactive2024-09hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.30.jsonCardiopulmonary Resuscitation Order Proceduresactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.31.jsonCardiopulmonary Resuscitation Procedures Groupingactive2024-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.32.jsonAdditional Portable Medical Order Proceduresactive2025-04hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.33.jsonInitial Treatment Portable Medical Order Procedures Groupingactive2024-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.34.jsonAdditional portable medical order Procedures Groupingactive2024-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.35.jsonMedically Assisted Nutrition Order Optionsactive2024-09hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.36.jsonMedically Assisted Nutrition Portable Medical Order Procedures Groupingactive2024-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.37.jsonHealthcare Agent Powersactive2024-11hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.38.jsonPersonal Health Goal Options LOINCactive2025-03hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.40.jsonPortable Medical Order Document Typesactive2025-04hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.41.jsonAdvance Healthcare Directive Document Types Grouperactive2025-04hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1115.8.jsonTreatment Intervention Preferences at End of Life LOINCactive2025-04hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.1.jsonRituximab Injectableactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.100.jsonPathological M Stage M1cactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.101.jsonPathological N Stage N3active2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.102.jsonN Stage pN1aactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.103.jsonN Stage pN1bactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.105.jsonPathological N Stage pN1miactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.106.jsonPathological N Stage N2bactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.107.jsonPathological N Stage N2aactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.108.jsonPathological N Stage N2active2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.109.jsonPathological N Stage N1bactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.110.jsonPathological N Stage N1aactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.112.jsonPathological N Stage N0active2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.114.jsonPathological T Stage T4dactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.115.jsonPathological T Stage T4cactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.116.jsonPathological T Stage T4bactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.117.jsonPathological T Stage T4aactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.118.jsonPathological T Stage T4active2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.120.jsonN Stage N2Cactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.121.jsonT Stage T3cactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.122.jsonT Stage T3bactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.123.jsonT Stage T3aactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.124.jsonPathological T Stage T3active2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.125.jsonT Stage T2cactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.126.jsonT Stage T2bactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.127.jsonT Stage T2aactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.128.jsonPathological T Stage T2active2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.129.jsonPathological T Stage T1cactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.132.jsonPathological T Stage T1bactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.135.jsonPathological T Stage T1aactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.136.jsonPathological T Stage T1active2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.137.jsonPathological T Stage T1micactive2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.139.jsonPathological T Stage T0active2024-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.142.jsonCancer Stage IIIactive2024-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.143.jsonCancer Stage IIIAactive2024-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.144.jsonCancer Stage IIIBactive2024-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.145.jsonCancer Stage IIICactive2024-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.146.jsonCancer Stage IVactive2024-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.147.jsonCancer Stage IVAactive2024-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.148.jsonCancer Stage IVBactive2024-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.149.jsonCancer Stage IVCactive2024-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.151.jsonCisplatin Injectableactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.153.jsonVinorelbine Injectableactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.154.jsonGemcitabine Injectableactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.155.jsonDocetaxelactive2024-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.156.jsonPemetrexed Injectableactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.158.jsonVinblastine Injectableactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.160.jsonECOG Performance Statusactive2024-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.161.jsonECOG Performance Statusactive2020-10hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.162.jsonECOG Performance Statusactive2022-03hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.164.jsonKarnofsky Performance Statusactive2024-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.165.jsonCarboplatin Injectableactive2020-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.166.jsonPaclitaxelactive2024-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.168.jsonDoxorubicin Injectableactive2022-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.169.jsonIrinotecan Injectableactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.179.jsonBevacizumab Injectableactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.181.jsonMethotrexateactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.184.jsonBreast Canceractive2022-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.185.jsonBreast Canceractive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.191.jsonCancer Stage IIactive2024-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.192.jsonCancer Stage IIAactive2024-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.193.jsonCancer Stage IIBactive2024-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.194.jsonPertuzumab Injectableactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.196.jsonIxabepilone Injectableactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.197.jsonGoserelinactive2024-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.200.jsonEpirubicin Injectableactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.202.jsonRamucirumab Injectableactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.204.jsonLetrozoleactive2024-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.206.jsonExemestaneactive2024-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.209.jsonFluorouracilactive2024-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.210.jsonCapecitabine Oralactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.222.jsonAprepitant Oralactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.223.jsonFosaprepitant Injectableactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.255.jsonColorectal Canceractive2021-12hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.256.jsonColorectal Canceractive2021-12hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1116.257.jsonColorectal Cancer Chemotherapyactive2023-12hl7rx